Skip to content
HelixEVOLabs home
Sign in
Fundamentals

Storage and stability of synthetic peptides

What the published literature reports about how lyophilised peptides and peptide solutions degrade, which residues are vulnerable, and the storage conditions used in analytical and assay work.

Last reviewed
2026-09-22
Reviewer
editorial review pending
Revision
1
Sources
3

A lyophilised peptide is not inert. Drying removes the solvent that carries most degradation chemistry, but several routes survive the loss of water, and all of them run faster as temperature rises. This page summarises what the published literature reports about those routes and about the conditions used to slow them. It describes handling in an analytical setting and nothing else.

The degradation routes

Four chemical and physical pathways account for most of what is observed in peptide stability studies.

Deamidation converts an asparagine or glutamine side-chain amide to a carboxylic acid, adding roughly one mass unit and introducing a negative charge 1. It proceeds through a cyclic succinimide intermediate, and the rate is strongly sequence-dependent: work on model peptides found that the volume and hydrophobicity of the residues at the two positions preceding the asparagine are of approximately equal importance in setting the rate 2. The same study observed apparent first-order kinetics in solution, and a different profile in the solid state, where the peptides plateaued while complexed with the formulation polymer 2. The mechanistic point that matters for dried material is that the succinimide route does not consume water, so removing water slows deamidation without abolishing it.

Oxidation attacks methionine most readily, with tryptophan, cysteine, histidine and tyrosine also susceptible; exposure to oxygen during shipping and storage, and the presence of transition metals, promote it 1. Each oxygen added shifts the mass by sixteen units, which makes the products straightforward to identify by mass spectrometry once they are looked for. Because atmospheric oxygen is the reagent, the gas left in a sealed vial is part of the storage condition, not an incidental detail.

Hydrolysis cleaves the peptide backbone, and is promoted at both acidic and alkaline extremes 1. It is chiefly a solution-phase concern.

Aggregation is physical rather than covalent: association into dimers, oligomers and larger species, driven by temperature stress, agitation and air–liquid interfaces, and often accelerated by prior oxidative damage 1. Aggregates can alter chromatographic behaviour and assay response without changing the intact mass of the monomer.

Conditions reported in the literature

The recommendations published for synthetic peptides used in mass-spectrometry assays are the most specific in the sources retrieved here, and are quoted as conditions used in that analytical context.

For storage beyond six months, that guidance specifies the lyophilised solid at −20 to −80 °C 3. For medium- to long-term storage of solutions it specifies a frozen high-concentration solution at or below −70 °C in sealed tubes, and for shorter periods of up to about three months, high-concentration solution at 4 °C or frozen at −20 to −80 °C 3.

The same source advises avoiding repeated freeze–thaw cycles as a general precaution, while reporting that in its own experiments peak areas did not differ significantly between refrigerated storage, a single freeze–thaw and ten cycles 3. That is a useful illustration of a wider point: freeze–thaw sensitivity is a property of a particular peptide and a particular solution, not a universal constant, and a general rule cannot be substituted for data on the material in hand.

Surfaces and concentration

Loss to container walls is a measurement problem rather than a chemical one, and it is most pronounced at low concentration. The published recommendations address it by choice of vessel, specifying silanised glass or polypropylene and other modified plastic surfaces, by keeping solutions relatively concentrated, and by adding peptide directly into the diluent rather than onto the tube wall 3. Adsorptive loss does not change the composition of what remains in solution, but it does change its concentration, which is why a discrepancy between weighed mass and measured response is not always a purity question.

Solvent choice

For dissolution, the mass-spectrometry recommendations give a starting composition of about 5% acetonitrile with 0.1 to 1% formic acid, with the organic proportion raised towards 30% acetonitrile for more hydrophobic sequences 3. Those conditions are reported as what suits chromatographic and mass-spectrometric work; they are not generalisable to other laboratory applications, and the appropriate solvent for any given experiment is determined by that experiment.

Excipients in dried preparations

Where a dried preparation is formulated rather than simply lyophilised from a volatile buffer, stabilisers are used. The categories described are non-reducing sugars, amino acids such as glycine, arginine and histidine, and osmolytes such as sorbitol and trehalose 1. A material supplied as the peptide alone carries none of this protection, so its stability rests on the storage conditions and the sealed vial rather than on formulation.

What this means for reported figures

Degradation rate is a function of sequence, salt form, residual moisture, headspace gas, pH and temperature together. A stability figure determined for one preparation of a peptide does not transfer to another preparation of the same peptide under different conditions, and the deamidation work above demonstrates how far rate can shift on sequence context alone 2.

That is why the compound pages on this site state solubility and solution-stability figures only where a peer-reviewed or pharmacopoeial source gives them for the compound concerned, and record the field as unverified where no such source exists. Figures traceable only to supplier catalogues are not reproduced here.

Purity and content figures describe a lot at the moment it was tested. Stability determines how long that description remains a fair account of what is in the vial, which is why a retest date accompanies a certificate rather than replacing it.

Questions this page answers

Why are lyophilised peptides stored cold rather than at room temperature?
Removing water slows but does not stop the chemical routes that degrade peptides, and the rate of every one of those routes rises with temperature. Published recommendations for peptides used in mass-spectrometry assays specify storage of the lyophilised solid at −20 to −80 °C for periods beyond six months.
Does freeze-drying stop degradation?
No. Deamidation proceeds through a cyclic succinimide intermediate whose formation does not consume water, so it can occur in a dried solid; oxidation continues in the presence of residual oxygen in the vial headspace. Drying slows these routes rather than eliminating them.
Which residues are most vulnerable?
Asparagine and glutamine are the principal sites of deamidation, and the rate depends measurably on the neighbouring residues. Methionine is the most oxidation-sensitive residue, with tryptophan, cysteine, histidine and tyrosine also susceptible.
Why do stability figures differ between sources?
Degradation rate depends on sequence, salt form, residual moisture, headspace, pH and temperature, so a figure measured for one preparation does not transfer to another. This site reports solubility and stability figures only where a peer-reviewed or pharmacopoeial source gives them for the compound in question.

References

  1. 1.Akbarian M, Chen S-H. Instability Challenges and Stabilization Strategies of Pharmaceutical Proteins. Pharmaceutics (2022). doi:10.3390/pharmaceutics14112533 PMID 36432723 · accessed 2026-09-22
  2. 2.Li B, et al.. Effect of N-1 and N-2 residues on peptide deamidation rate in solution and solid state. The AAPS Journal (2006). doi:10.1208/aapsj080120 PMID 16584125 · accessed 2026-09-22
  3. 3.Hoofnagle AN, Whiteaker JR, Carr SA, et al.. Recommendations for the generation, quantification, storage and handling of peptides used for mass spectrometry-based assays. Clinical Chemistry (2016). doi:10.1373/clinchem.2015.250563 PMID 26719571 · accessed 2026-09-22
For laboratory research use only. This article summarises published literature and regulatory records; it does not describe or recommend any use of a material in or on humans or animals.
Cite this page
Harvard
HelixEVO Labs (2026) Storage and stability of synthetic peptides. Available at: https://helixevo.net/knowledge-base/fundamentals/storage-and-stability (Accessed: 2026-09-25).
APA
HelixEVO Labs. (2026). Storage and stability of synthetic peptides. https://helixevo.net/knowledge-base/fundamentals/storage-and-stability
BibTeX
@misc{helixevo-2026-storage-and-stability-of-synthetic-pepti,
  title = {Storage and stability of synthetic peptides},
  author = {{HelixEVO Labs}},
  year = {2026},
  howpublished = {\url{https://helixevo.net/knowledge-base/fundamentals/storage-and-stability}},
  note = {Reviewed 2026-09-22; accessed 2026-09-25}
}
Revision history
  1. r1 · 2026-09-25 · Initial import